Document ID: chunk:federal_register_of_legislation:F2024L00675:clause:1_2
Version: federal_register_of_legislation:F2024L00675
Segment Type: clause
Provision Reference: sch 1 cl 2
Character Range: 7892–9669

2                                                                                  the aggregated visual for a medicine           the following persons, bodies or authorities:                                                       to facilitate the consideration, analysis and communication of medicine availability data to support the management of medicine shortages and discontinuations, including the securing of an alternative treatment
                                                                                                                                    (a) the MAWG;
                                                                                                                                    (b) an expert adviser in the MAWG (if any);
                                                                                                                                    (c) a MSAG;
                                                                                                                                    (d) the part of the Department responsible for administering the Pharmaceutical Benefits Scheme;
                                                                                                                                    (e) the Foreign Affairs Department;
                                                                                                                                    (f) the Home Affairs Department;
                                                                                                                                    (g) the Industry Department;
                                                                                                                                    (h) the NEMA